AIIMS-led study shows two-medicine combination therapy effective in controlling high BP
The study, in partnership with the Centre for Chronic Disease Control (CCDC) and Imperial College London, UK, compared three widely used drug combinations: amlodipine plus perindopril, amlodipine plus indapamide, and perindopril plus indapamide.
The first randomised trial to test three different two-drug combination pills among South Asians involved over 1,200 patients with uncontrolled hypertension across 32 hospitals in India.
'All three combinations worked equally well in reducing blood pressure and were safe for patients,' revealed the study, published in the journal Nature Medicine.
The findings showed that either of the two-drug combinations led to a significant drop in blood pressure after 6 months -- by around 14/8 mmHg when measured over 24 hours and about 30/14 mmHg in clinic settings.
'Nearly 70 per cent of patients got their blood pressure under control, a huge improvement over the current national average. And the pills were safe and easy to use. This study gives clear guidance for better hypertension care,' said Dr Ambuj Roy, Professor of Cardiology at AIIMS Delhi.
'This study shows that a single daily pill with two drugs can be a simple and powerful way to manage blood pressure in Indian and South Asian patients,' said Dr Dorairaj Prabhakaran, Executive Director of CCDC.
High blood pressure (hypertension) is the leading risk factor for death worldwide and affects over 300 million people in India alone. Treating it early and effectively can prevent heart attacks, strokes, and kidney failure.
Doctors often recommend starting with two medications in one pill to control blood pressure better and help patients stick to treatment. But until now, no large study had tested which combinations worked best for South Asians, who make up a quarter of the world's population.
The results revealed that nearly 70 per cent of patients with any of the dual drug therapy reached the recommended blood pressure target of below 140/90 mmHg -- five times higher than India's current average control rate.
Less than 3 per cent of patients reported side effects serious enough to stop treatment. 'These findings can help guide doctors and policymakers. If added to India's list of essential medicines and made available at primary health centres, these pills could greatly improve blood pressure control in the country,' Prabhakaran said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
an hour ago
- The Hindu
28 out of 33 districts in Telangana have higher concentration of fluoride in groundwater: Report
Over 36% of Indian districts or 263 out of the total 722 districts in the country now have groundwater concentration of fluoride that is higher than the permissible 1.5 mg/L. The number of districts with high concentration of fluoride in water (1.5 mg/L) has increased from 207 in 2017 to 263 in 2023. These are some of the findings of the National Ground Water report released recently. One of the findings in the report is about the surge in fluoride concentration in groundwater that is linked to overexploitation. The Bureau of Indian Standards recommends an upper desirable limit of 1.0 mg/L of fluoride in drinking water, which can be extended to 1.5 mg/L in case no alternative source of water is available. Higher concentration of fluoride in drinking water is linked to a host of debilitating diseases like waterborne fluorosis, dental and skeletal fluorosis. It can cause staining of tooth enamel, while higher concentrations (5.0 to 10 mg/L) can lead to pathological changes like stiffness of the spine and difficulty in natural movement. This significant increase in the percentage of locations has been mainly contributed by states like Rajasthan, Haryana, Punjab and Telangana. 'The concentration of chemicals is increasing as we are digging deeper borewells across the country. There is increasing water stress and this is translating into higher extraction of groundwater. A spoonful of salt will be less salty in a full glass of water, it will be more salty as the quantity of water declines,' says K. Laxma, Director, Telangana Ground Water department explaining the rise in fluoride concentration in groundwater. 'Groundwater Over-Extraction (Anthropogenic Influence) is a significant factor exacerbating fluoride contamination, particularly in the southern and western States known for over-exploitation,' says the Annual Ground Water Report 2024 released by the Government of India. This is borne out by the fact that the post-monsoon sampling showed a drop in concentration of fluoride. 'The monsoon recharge appears to have had a dilution effect on the fluoride concentrations in groundwater across all the States, as reflected by the significant number of samples showing improvement in fluoride levels after recharge,' according to the report. Out of the 33 districts in Telangana, 28 have anomalous values of Fluoride (> 1.5 mg/L) in groundwater at one or more locations. Only Rajasthan has 31 districts with higher values of fluoride. The most severely affected States, with more than 10% of their water samples exceeding the permissible fluoride limit, include Rajasthan (43.17%), Haryana (23.66%), Karnataka (17.68%), Telangana (14.87%), Gujarat (13.92%), Punjab (13.77%) and Andhra Pradesh (11.31%). The monsoon season has a positive dilution effect on fluoride concentrations. In 2023, the percentage of samples exceeding 1.5 mg/L decreased from 9.14% in pre-monsoon to 7.74% in post-monsoon. In Telangana, out of the samples analysed in 2023, the percentage of locations exceeding 1.5 mg/L fluoride decreased from 20% in pre-monsoon to 15.49% in post-monsoon.
Time of India
3 hours ago
- Time of India
AIIMS CRE 2025: M.Sc. Nursing seat allotment 2nd round result out at aiimsexams.ac.in, reporting begins 11 August
AIIMS Nursing: The All India Institute of Medical Sciences (AIIMS), New Delhi, has released the 2nd round result of online seat allocation for the Nursing course for the August 2025 session. Tired of too many ads? go ad free now The list of allotted seats, including AIIMS and subject/specialty, based on candidates' preferences submitted between 11:00 AM on July 14 and 5:00 PM on July 19, 2025, is now available on the official website, Eligible candidates who have been allotted a seat in this round are required to report to the allotted AIIMS between 11:00 AM on August 11, 2025, and 5:00 PM on August 14, 2025. They must carry original documents or a Demand Draft (DD) of INR 1 lakh to complete the admission formalities. Seat allocation done on the basis of available vacancies and merit The 2nd round of seat allocation was carried out for seats that remained vacant after the 1st round. The seat allocation order was based on the merit list used in the 1st round, including institutional preferences. Candidates who submitted valid OBC/EWS certificates at the time of registration or by July 19, 2025, were considered under their respective categories. Others were converted to the UR category. Candidates who did not participate in the 1st round are not eligible for the 2nd round but may take part in the open round, if held. Foreign nationals and sponsored candidates are not included in this list. Category-wise last rank details The last rank at which seats were allotted in the 2nd round across various categories is as follows: • PWBD (excluding in-service): 263 • UR: 1091 • OBC: 661 • SC: 777 • ST: 514 • EWS: Not specified • In-service (AIIMS New Delhi): Not specified Instructions for candidates allotted seats Candidates must download the offer letter and seat allocation letter from the AIIMS portal. Tired of too many ads? go ad free now At the time of reporting, they must either submit original documents or a DD of INR 1 lakh in favour of AIIMS MAIN GRANT payable at Ansari Nagar Branch. If the DD is submitted, original documents must be deposited within five days to avoid cancellation. Candidates allocated a different AIIMS in the 2nd round from the 1st round must report to the new institute. Documents/DDs will be transferred internally by AIIMS. Failure to accept the allotted seat by 5:00 PM on August 14, 2025, will be treated as a refusal. In such cases, the seat will be declared vacant for the open round, and previous claims will be forfeited. Document requirements and category certificate policy Allotted candidates must provide the following in original along with a set of self-attested photocopies or a DD: • Offer letter and seat allocation letter • Final registration slip and admit card • Proof of date of birth (Class 10 certificate) • Qualifying degree certificate and marksheet • RN/RM registration certificate • Recognition proof of qualifying institute • Valid SC/ST/OBC/EWS certificate (if applicable) • PWBD certificate from an authorised board (if applicable) OBC and EWS certificates must be in the Central Government format, issued between April 1, 2025, and May 15, 2025. Only certificates received by July 19, 2025, via portal or email have been accepted. Invalid or late certificates led to category conversion. How to check AIIMS Nursing 2nd round seat allotment result at Step 1: Visit the official AIIMS examination website at Step 2: Click on the "Academic Courses" section on the homepage Step 3: Select " Nursing" from the list of courses Step 4: Click on the link titled "2nd Round Seat Allocation Result – Nursing August 2025 Session" Step 5: Download the PDF file and check your seat allotment and category-wise rank details Further rounds and reporting instructions Details regarding the open round of seat allocation, if any, will be announced on the official website. All candidates are advised to regularly check for updates. TOI Education is on WhatsApp now. Follow us .
Hans India
3 hours ago
- Hans India
India's 1st animal stem cell biobank, lab to boost regenerative medicine & therapies for livestock
New Delhi: India on Saturday got the first animal stem cell biobank and animal stem cell laboratory that will focus on regenerative medicine and therapies for livestock. Inaugurated by Union Minister of State (Independent Charge) Science & Technology, Dr. Jitendra Singh, the biobank and lab is situated at the National Institute of Animal Biotechnology (NIAB), Hyderabad. The cutting-edge facility of Animal BioBank is spread over 9,300 sq ft and has been constructed at a cost of RS 1.85 crore. The laboratory is equipped with a stem cell culture unit, 3D bioprinter, bacterial culture lab, cryostorage, autoclave rooms, advanced air handling systems, and uninterrupted power backup. It will advance research in disease modelling, tissue engineering, and reproductive biotechnology. With support from the National Biopharma Mission (NBM) of DBT–BIRAC, the facility will be expanded to enable biobanking of animal stem cells and their derivatives. 'We had such facilities for human stem cells, but hardly any for animal cells. The best of NIAB, and the best of Indian biotechnology, is yet to come,' Singh said, adding that these facilities will contribute "to making India future-ready". 'We will not lag behind when the next industrial revolution—driven by biotechnology—takes over. The economy will shift from manufacturing to regenerative and genetic processes, and India has already initiated this transition,' he added. The Minister also laid the foundation stone of a new hostel block and Type-IV quarters at NIAB, approved by the Department of Biotechnology at a total cost of Rs 19.98 crore. The infrastructure will cater to the needs of research scholars, faculty, and staff, fostering a vibrant academic and innovation ecosystem. In addition, Singh launched innovative veterinary diagnostic tools designed to revolutionise animal health management and support the 'One Health' approach. These include a field-deployable, DIVA-capable diagnostic kit for early and accurate detection of Brucella species; a cost-effective on-site diagnostic assay for subclinical and clinical mastitis in dairy cattle; a portable antimicrobial sensitivity testing device providing results within two hours to promote responsible antibiotic use; a sensitive and specific test for Toxoplasma gondii infection in animals; an indigenously developed rapid strip for large-scale surveillance of Japanese Encephalitis in animals and humans. 'These innovations will boost agriculture-linked GDP, enhance livestock productivity, and pave the way for an 'Evergreen Revolution' in the animal husbandry sector,' the Minister emphasised. On the agricultural front, 'these releases mark a new phase of animal-based agricultural productivity -- an 'Evergreen Revolution'. With 18 per cent of GDP from agriculture and 60 per cent of our workforce depending on it, innovations in veterinary health will have a transformative impact,' he said. 'One rupee spent on agricultural research yields a return of Rs 13, and linking industry partners from day one ensures these technologies reach the ground,' Singh added.
